Zealand Pharma: names Matthew Dallas new CFO
(CercleFinance.com) - Danish biotechnology company Zealand Pharma on Wednesday appointed Matthew Dallas as its new chief financial officer as from the beginning of October.
The US executive will replace Ivan Moller, who had been serving as Zealand's interim CFO since April 2019.
Most recently, Dallas served as CFO at US biotechnology firm Aveo Pharmaceuticals. He was previously CFO at CoLucid Pharmaceuticals, which was later acquired by Eli Lilly.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The US executive will replace Ivan Moller, who had been serving as Zealand's interim CFO since April 2019.
Most recently, Dallas served as CFO at US biotechnology firm Aveo Pharmaceuticals. He was previously CFO at CoLucid Pharmaceuticals, which was later acquired by Eli Lilly.
Copyright (c) 2019 CercleFinance.com. All rights reserved.